Search
The Malpractice Experience of Neurosurgeons 2014–2019: Patient Selection and Communication May Mitigate Risk of Claims (Abstract)
The Doctors Company conducted an analysis of medical malpractice claims against neurosurgeons that closed between the years of 2014 and 2019. This evaluation included 302 claims and lawsuits, and examined allegations, diagnoses, procedures, and contributing factors, as well as indemnities and expenses paid. The claims experience of neurosurgeon members of The Doctors Company was then benchmarked against a national sample of other neurosurgeons.
The Doctors Company Names Christa Steele, MBA, to Board of Governors
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, is pleased to announce the appointment of Christa Steele, MBA, to its Board of Governors. Ms. Steele is a financial and governance executive with decades of corporate leadership experience across a wide range of industries.
Sep 01, 2023
Industry and Company News
Announcements in the third quarter of 2023: an appointment to our Board of Governors, the passing of a co-founding board member, and the results of our 2022 Member Experience Survey.
From
The Doctor’s Advocate
Professional Education
Module 5: Eliminating Stigma Through Clinical Understanding of Substance Use Disorder (Innovations for Smart Approaches in Safe Prescribing)
You will explore how having a working awareness of neurobiology, psychology, and heritability of addiction positively impacts holistic treatment of opioid misuse. This module will examine how the etiology of stigma and how internalized biases impact the care of patients who misuse opioids. Lastly, this program will provide resources on how to connect to treatment for substance use disorder. This module consists of five audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Professional Education
Delayed Diagnosis of Malignancy: Case Review for Advanced Practice Clinicians
In reviewing closed malpractice claims, The Doctors Company identified delayed diagnosis of a malignancy as a reoccurring problem. The following highlights the importance of recognizing a spinal abnormality and recommending further follow up of a lesion seen on imaging. Contributing factors include misinterpretation of radiologic studies, narrow diagnostic focus, lack of communication, and failure to establish a differential diagnosis.
March 19, 2025, AM Best
AM Best Comments on Credit Ratings of The Doctors Company Insurance Group Members Following Announced Acquisition of ProAssurance Corporation
AM Best has commented that the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of “a+” (Excellent) of the members of The Doctors Company Insurance Group (TDC Group) (Napa, CA) are unchanged following the March 19, 2025, announcement that TDC Group will acquire all outstanding shares of ProAssurance Corporation (PRA) (NYSE: PRA) (Birmingham, AL). The outlook of TDC Group’s Credit Ratings (ratings) is stable.
Video Oct 14, 2022
New Thinking About Primary Care and Practice Redesign
Megan Mahoney, MD, MBA, Professor and Chair of the UCSF Department of Family and Community Medicine and member of The Doctors Company Board of Governors, explains how she developed a new model for providing the most efficient and high-quality care in her practice.
September 28, 2023, Medical Economics
The Evolution of Primary Care and the Growing Role of Advanced Practice Clinicians
Laura Kline, MBA, CPCU, MBA, CPCU, Senior Vice President, Business Development, The Doctors Company and TDC Group, discusses how advanced practice clinicians are part of the solution to addressing the physician shortage.
December 10, 2024, Medscape
Malpractice in the Age of AI
Deepika Srivastava, Chief Operating Officer of The Doctors Company, part of TDC Group, provides insights on the intersection of artificial intelligence (AI) and malpractice risk in healthcare.